share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP：信函
美股SEC公告 ·  07/16 12:40

Moomoo AI 已提取核心信息

60 Degrees Pharmaceuticals, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-280796. The company, headquartered in Washington, D.C., seeks to have the Registration Statement become effective at 9:00 a.m. Eastern Time on July 18, 2024, or as soon thereafter as practicable. This request, made pursuant to Rule 461 of the Securities Act of 1933, comes with the acknowledgment from the company that the SEC's declaration of effectiveness does not preclude further SEC action regarding the Registration Statement, nor does it absolve the company of its responsibility for the adequacy of the disclosure within the Registration Statement. The company also recognizes that it cannot use the SEC's comments or the effectiveness of the Registration Statement as a defense in any legal proceedings. Upon effectiveness, 60 Degrees Pharmaceuticals has requested oral confirmation from the SEC and a written order verifying the effective time and date to be sent to their counsel, Sichenzia Ross Ference Carmel LLP.
60 Degrees Pharmaceuticals, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-280796. The company, headquartered in Washington, D.C., seeks to have the Registration Statement become effective at 9:00 a.m. Eastern Time on July 18, 2024, or as soon thereafter as practicable. This request, made pursuant to Rule 461 of the Securities Act of 1933, comes with the acknowledgment from the company that the SEC's declaration of effectiveness does not preclude further SEC action regarding the Registration Statement, nor does it absolve the company of its responsibility for the adequacy of the disclosure within the Registration Statement. The company also recognizes that it cannot use the SEC's comments or the effectiveness of the Registration Statement as a defense in any legal proceedings. Upon effectiveness, 60 Degrees Pharmaceuticals has requested oral confirmation from the SEC and a written order verifying the effective time and date to be sent to their counsel, Sichenzia Ross Ference Carmel LLP.
60 Degrees Pharmaceuticals, Inc.已正式要求美国证券交易委员会（SEC）加快在编号为333-280796的文件下初始提出的S-3表格的注册声明的生效日期。总部位于华盛顿特区的该公司希望在2024年7月18日美国东部时间上午9:00使注册声明生效，或尽可能早地生效。根据1933年证券法的规则461制定的此请求，该公司承认SEC的有效声明不排除对注册声明的进一步SEC行动，也不免除公司对注册声明中披露充分的责任。该公司还认识到，它不能把SEC的注释或注册声明的生效作为在任何法律诉讼中的辩护理由。在生效后，60 Degrees Pharmaceuticals要求从SEC获得口头确认并发送书面订单以验证生效时间和日期，并将其发送给他们的律师事务所Sichenzia Ross Ference Carmel LLP。
60 Degrees Pharmaceuticals, Inc.已正式要求美国证券交易委员会（SEC）加快在编号为333-280796的文件下初始提出的S-3表格的注册声明的生效日期。总部位于华盛顿特区的该公司希望在2024年7月18日美国东部时间上午9:00使注册声明生效，或尽可能早地生效。根据1933年证券法的规则461制定的此请求，该公司承认SEC的有效声明不排除对注册声明的进一步SEC行动，也不免除公司对注册声明中披露充分的责任。该公司还认识到，它不能把SEC的注释或注册声明的生效作为在任何法律诉讼中的辩护理由。在生效后，60 Degrees Pharmaceuticals要求从SEC获得口头确认并发送书面订单以验证生效时间和日期，并将其发送给他们的律师事务所Sichenzia Ross Ference Carmel LLP。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间